Connor Clark & Lunn Investment Management Ltd. bought a new stake in shares of Owens & Minor, Inc. (NYSE:OMI – Free Report) in the 1st quarter, according to its most recent 13F filing with the Securities & Exchange Commission. The firm bought 13,806 shares of the company’s stock, valued at approximately $201,000.
Several other large investors also recently modified their holdings of the business. First Trust Advisors LP increased its stake in shares of Owens & Minor by 11.9% in the fourth quarter. First Trust Advisors LP now owns 110,033 shares of the company’s stock valued at $2,149,000 after purchasing an additional 11,741 shares during the period. Smith Graham & Co. Investment Advisors LP increased its stake in shares of Owens & Minor by 19.4% during the 1st quarter. Smith Graham & Co. Investment Advisors LP now owns 520,461 shares of the company’s stock worth $7,573,000 after purchasing an additional 84,634 shares during the last quarter. Swiss National Bank grew its stake in Owens & Minor by 2.0% in the 4th quarter. Swiss National Bank now owns 174,900 shares of the company’s stock valued at $3,416,000 after buying an additional 3,400 shares during the last quarter. First Eagle Investment Management LLC grew its stake in Owens & Minor by 3.5% in the 4th quarter. First Eagle Investment Management LLC now owns 147,117 shares of the company’s stock valued at $2,873,000 after buying an additional 5,000 shares during the last quarter. Finally, UBS Group AG grew its stake in Owens & Minor by 110.0% in the 4th quarter. UBS Group AG now owns 95,224 shares of the company’s stock valued at $1,860,000 after buying an additional 49,888 shares during the last quarter. 98.04% of the stock is currently owned by institutional investors and hedge funds.
Owens & Minor Trading Up 1.2 %
Shares of OMI stock opened at $16.41 on Tuesday. Owens & Minor, Inc. has a 12-month low of $11.79 and a 12-month high of $30.67. The company has a market capitalization of $1.26 billion, a P/E ratio of -12.62, a P/E/G ratio of 4.18 and a beta of 0.51. The firm has a 50-day moving average price of $18.56 and a 200 day moving average price of $15.02. The company has a quick ratio of 0.65, a current ratio of 1.34 and a debt-to-equity ratio of 2.58.
Insider Activity at Owens & Minor
In other Owens & Minor news, CEO Edward A. Pesicka sold 118,927 shares of Owens & Minor stock in a transaction that occurred on Tuesday, June 6th. The shares were sold at an average price of $20.86, for a total value of $2,480,817.22. Following the transaction, the chief executive officer now owns 1,142,716 shares of the company’s stock, valued at $23,837,055.76. The sale was disclosed in a legal filing with the SEC, which is accessible through this link. In related news, CEO Edward A. Pesicka sold 118,927 shares of the business’s stock in a transaction on Tuesday, June 6th. The shares were sold at an average price of $20.86, for a total transaction of $2,480,817.22. Following the transaction, the chief executive officer now directly owns 1,142,716 shares in the company, valued at $23,837,055.76. The sale was disclosed in a filing with the SEC, which is available through this link. Also, CEO Edward A. Pesicka sold 38,780 shares of the business’s stock in a transaction on Thursday, June 15th. The stock was sold at an average price of $19.24, for a total transaction of $746,127.20. Following the transaction, the chief executive officer now owns 747,153 shares in the company, valued at $14,375,223.72. The disclosure for this sale can be found here. Over the last 90 days, insiders sold 286,635 shares of company stock worth $5,958,129. 3.59% of the stock is currently owned by company insiders.
Analyst Upgrades and Downgrades
OMI has been the subject of a number of research reports. Robert W. Baird increased their price target on shares of Owens & Minor from $18.00 to $21.00 in a report on Monday, May 8th. StockNews.com started coverage on shares of Owens & Minor in a report on Thursday, August 17th. They issued a “hold” rating for the company. Credit Suisse Group raised their price objective on shares of Owens & Minor from $18.00 to $19.00 and gave the stock a “neutral” rating in a report on Tuesday, August 8th. UBS Group raised their price objective on shares of Owens & Minor from $22.00 to $24.00 in a report on Monday, May 8th. Finally, Citigroup reduced their price objective on shares of Owens & Minor from $23.00 to $21.00 in a report on Friday, August 4th. Two research analysts have rated the stock with a sell rating and four have given a hold rating to the company’s stock. Based on data from MarketBeat, Owens & Minor presently has a consensus rating of “Hold” and a consensus target price of $19.83.
Check Out Our Latest Stock Report on Owens & Minor
Owens & Minor Company Profile
Owens & Minor, Inc, together with its subsidiaries, operates as a healthcare solutions company worldwide. It operates in two segments, Products & Healthcare Services and Patient Direct. The Products & Healthcare Services segment offers a portfolio of products and services to healthcare providers and manufacturers.
Featured Articles
- Five stocks we like better than Owens & Minor
- Are Penny Stocks a Good Fit for Your Portfolio?
- 3 Reasons High-Yield Bloomin’ Brands is About to Blossom
- Best Restaurant Stocks to Invest in Now
- 5 Computer Vision Stocks with a Clear Path to Growth
- What is an Earnings Surprise?
- 3 Reasons Workday Stock Is Setting Up For A New Rally
Want to see what other hedge funds are holding OMI? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for Owens & Minor, Inc. (NYSE:OMI – Free Report).
Receive News & Ratings for Owens & Minor Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Owens & Minor and related companies with MarketBeat.com's FREE daily email newsletter.